Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 24 June 2013 | By Ansis Helmanis,
Health Canada has issued guidance on Determining Prescription Status for Human and Veterinary Drugs that explains the principles and factors that the agency considers when deciding whether a drug should be classified as a prescription or non-prescription product.
The guidance applies to both human and veterinary drugs and to all additions and removals from the list of prescription drugs that replaced the Food and Drug Regulations' "Schedule F" in 2012, although it does not apply to decisions as to whether a drug should be a controlled substance.
The guidance is intended to make the classification decision-making process more transparent by explaining the three broad principles that govern a determination as to prescription status:
Health Canada: Determining Prescription Status for Human and Veterinary Drugs
Read all Breaking News from RegLink
Regulatory Focus newsletters
All the biggest regulatory news and happenings.